Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study. (1st March 2018) - Girolomoni, G.; Feldman, S.R.; Emery, P.; Ghil, J.; Keum, J.W.; Cheong, S.Y.; Hong, E.